I am an independent Medicare broker who spends every fall sitting at kitchen tables in western Pennsylvania, sorting through plan notices, drug lists, and provider directories with people who are tired of being sold to. That work has taught me that the 2027 conversation really starts before the glossy mailers show up. By the time most people ask me for help, they already have a stack of papers and a strong opinion based on one TV ad. I would rather start earlier, while there is still room to think clearly.
What I think is knowable right now
As of April 2026, I do not have a real 2027 plan book to spread across the table, and neither does anyone else selling honestly. Medicare’s annual Open Enrollment still runs from October 15 through December 7, and changes made in that window take effect January 1 of the following year. The official Medicare handbook for the new plan year is also sent out in late September, which is why I tell people not to expect hard 2027 plan details in the spring.
That does not mean I tell people to wait and do nothing. I use the spring and summer to figure out what would actually matter if a plan changed one copay, dropped one hospital system, or moved a favorite drug to a higher tier. Most people wait too long. By October, they are reacting to headlines instead of comparing the parts of coverage they will touch every month.
I also remind clients that private Medicare health and drug plans can change each year. The changes are not always dramatic, but a small shift in network rules or drug costs can create a much bigger problem than a flashy dental extra can solve. I have seen people stay in the same plan for 6 straight years because the card looked familiar, even though their specialist left the network two years earlier.
How I build a shortlist before open enrollment
Long before I compare plans, I build a one page worksheet with four columns. In the first column I write every doctor the client wants to keep, even the podiatrist they only see twice a year. In the second, I list pharmacies in the order they actually use them. In the third, I write down each prescription, the dose, and whether it is taken every month or only now and then.
The fourth column is where the real work begins. I mark travel habits, preferred hospitals, and whether a person would rather pay a higher monthly premium to smooth out bad months or gamble on lower premiums and bigger bills later. Small details decide everything. A customer last spring told me she did not care about gym perks at all, but she cared very much about keeping the cancer center that was 35 minutes from her house instead of driving nearly 2 hours.
When someone wants a plain starting point instead of a sales pitch, I may suggest a resource like Medicare Plans for 2027 to help frame the questions they should ask once official plan materials are released. I do that only after I have a clean medication list and a provider list, because broad comparisons are useful only if they connect back to a real person’s care. A website can help someone organize their thinking, but it cannot tell them whether their endocrinologist is still in network at the office they actually visit.
I usually narrow the first round to three options, sometimes four if the person splits time between two counties or uses one especially expensive medication. More than that becomes noise. People like the idea of looking at 12 plans because it feels thorough, but almost nobody makes a better decision once the choices stop being distinct and start blending together.
The tradeoffs I push people to notice first
The first number I circle is not always the monthly premium. I look at the maximum out of pocket, the specialist copay, the inpatient hospital cost sharing, and how the drug coverage behaves after an ugly month. A plan can look cheap in January and feel very expensive by August if someone lands in the hospital, starts a high cost medication, or needs physical therapy twice a week.
I spend a lot of time on networks because people underestimate how often they change and how messy the checks can be. The card is not the coverage. A plan may include a hospital system in one county and exclude a clinic using the same brand name in the next county over, which is why I check office locations one by one instead of assuming the logo tells the story.
Prior authorization is another place where I slow the conversation down. Some clients are willing to trade a lower premium for more management if they rarely use care and love the plan’s extra benefits. Others know that one delay on an MRI, rehab stay, or specialist referral would raise their blood pressure more than a slightly higher premium ever could. I have learned to ask one blunt question here: do you want fewer moving parts, or are you comfortable dealing with more plan rules to save money up front.
I also try to cool down the excitement around extras. Dental, vision, hearing, over the counter allowances, and grocery style benefits can matter, and I do not dismiss them, but I rank them after core medical access and drug coverage every time. A man I helped a while back kept coming back to a modest quarterly allowance, and I had to walk him back to the fact that his cardiologist would be out of network under that same plan. That kind of trade is rarely worth it.
Who I tell to think beyond a Medicare Advantage plan
I work with plenty of people who do well in Medicare Advantage, especially those with stable doctors, predictable prescriptions, and comfort with local networks. Still, I never assume it is the right lane for everyone entering 2027. People with two or three active specialists, frequent imaging, or a habit of spending long stretches in another state often need a broader conversation than a simple premium comparison can provide.
That is when I walk through Original Medicare, a Part D drug plan, and Medigap. Under federal law, the best known Medigap enrollment window is the 6 month period that starts when a person is 65 or older and enrolled in Part B, and after that window the rules can get tougher depending on timing and state protections. I do not use that point to scare anyone, but I do use it to explain why delaying the Medigap conversation can close off options later.
I have seen this play out with people who were healthy at 65 and felt perfectly fine picking the lowest premium Medicare Advantage plan on the page. Then 4 years later they were managing a serious diagnosis, seeing specialists across two health systems, and suddenly cared a lot more about broad access than about a low premium. That does not make the first decision foolish. It just means the best choice at 65 and the best choice at 69 can be very different.
I also bring up Special Enrollment Periods because life does not always line up with the fall calendar. A move, loss of other coverage, or certain plan changes can create another chance to adjust Medicare Advantage or Part D choices outside the standard October 15 to December 7 window. People feel calmer once they know a bad fit is not always locked in for a full year, although the exact options depend on the life event.
What I want people to do before the 2027 shopping season starts
I want every client to do three boring things before September. First, make a current medication list that includes dosage and frequency, because memory gets fuzzy fast. Second, write down every doctor and facility you would hate to lose, even if you only go once a year. Third, open every letter from your current plan instead of stacking it on the counter and promising yourself you will deal with it later.
I also tell people to pay attention to what changed in their own health over the last 12 months. Maybe a new diagnosis showed up. Maybe you started using an out of town specialist, or maybe you finally admitted that mail order prescriptions are a hassle and you want a local pharmacy again. Those changes matter more than broad claims about which company is supposedly the best for everybody.
By the time October gets here, I want the decision to feel smaller, not bigger. That usually means I have already ruled out the plans that miss one essential doctor, one expensive drug, or one hospital system a client truly relies on. Then the final choice becomes a clean comparison between a few realistic options instead of a panicked search through dozens of lookalike brochures.
That is how I am approaching Medicare plans for 2027 from my desk right now. I am not pretending the final plan details are already here, and I am not asking people to pick blind. I am asking them to prepare in a way that lets the official information mean something once it lands. The people who do that usually sound a lot less overwhelmed by December.